ZZZahid Zahidov

Zahid Zahidov

*This is an algorithmically generated author record based on publicly available information.

Zahid Zahidov has a total of 2 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Use of Ultrasound-Guided Percutaneous Microwave Ablation in the Treatment of Hepatic Cavernous Hemangioma: A Prospective Single-Center Study

    by Zahid Zahidov, Tapdıq Memmedov, Zülfi Zahidli

    Background/Aim: Hepatic cavernous hemangioma (HCH) is the most common benign liver tumor, but the management of small lesions remains controversial. This prospective study evaluated the efficacy, safety, and short- and long-term clinical outcomes of ultrasound (US)-guided percutaneous microwave (MW) ablation in patients with HCH under 5 cm exhibiting significant growth during follow-up.Materials and Methods: Between March 2010 and February 2015, 38 patients with HCH were prospectively enrolled at the Department of General Surgery, I.M. Sechenov First Moscow State Medical University (Moscow, Russia); those with lesions larger than 5 cm were excluded. Diagnosis was confirmed by contrast-enhanced multislice computed tomography (CT), and patients were followed with serial US and CT. Thirteen patients (34.2%) who showed a 2–2.5-fold increase in lesion size within 1.5–3 years underwent US-guided percutaneous MW ablation under intravenous anesthesia (14G probe; 100–120°C; 10–20 minutes). Patients were followed with clinical examination, liver function tests, and imaging.Results: The 13 treated patients (mean age 44 years; 9 women, 4 men) had 12 solitary and 1 multiple (four lesions) hemangiomas, predominantly right-lobed. Three patients (23.1%) were asymptomatic and ten (76.9%) had right upper-quadrant pain. A single session sufficed in 11 patients (84.6%); 2 (15.4%) required a second session for recurrence. Transient 2–3-fold ALT/AST elevations normalized by day 5. Six patients developed transient fluid collections that resolved spontaneously within 6 months; no major complications or procedure-related mortality occurred. Over a mean follow-up of 20 months (range 8–32), the ablation zone was replaced by fibrotic tissue in all patients.Conclusion: US-guided percutaneous MW ablation is an effective, safe, and organ-preserving minimally invasive option for small hepatic cavernous hemangiomas with documented growth, offering a feasible alternative between observation and surgical resection.Keywords: Hemangioma, Liver Neoplasms, Microwave Ablation, Ultrasonography